FRANKFURT - Bayer AG CEO Werner Wenning said Monday the German drugs and chemical group faces 3,500 damages suits in the United States following the recall last year of Baycol, its cholesterol drug.

Baycol, which was sold under the name Lipobay in countries outside the United Sates, was recalled in August 2001 after it was linked to more than 50 deaths worldwide. The number of deaths linked to Baycol has since risen to more than 100.

(via Reuters)